The U.S. Food and Drug Administration has approved the humanized monoclonal antibody Zynyz (retifanlimab-dlwr) as the first first-line treatment for advanced anal cancer.
This article was originally published on MedicalXpress.com
FDA approves Zynyz as first-line treatment for advanced anal cancer
You may also be interested in:
The Latest
Avoiding Common Relationship Mistakes for a Happier Love Life
Fostering a rewarding and fulfilling relationship is no easy task. You and your partner are only human, and, as the saying goes, you are going to make mistakes. However, learning the common relationship mistakes and […]
The Latest
PetVet Dx Revolutionizes Wildlife Conservation with AI and Molecular Diagnostics to Combat Incurable CWD in Deer and Elk
Chronic wasting disease (CWD), a devastating prion illness that affects North American cervids like deer and elk, poses a grave threat to their well-being and conservation efforts. Furthermore, it presents a potential risk of human […]
The Latest
Why you should stop buying vitamins and get more sleep instead
Almost half of all Canadians regularly take at least one nutritional supplement such as vitamins, minerals, fibre supplements, antacids and fish oils. Many of these individuals are healthy and hoping to improve general well-being or prevent chronic […]
Read More:
-
A new study published in The Lancet Child & Adolescent Health suggests that parental or caregiver intuition may outperform some traditional early warning systems in [...]
-
Long COVID—symptoms that linger long after the initial viral infection—can affect people of every age, including children. But the lasting symptoms in an infant, toddler, [...]
-
Robert F. Kennedy Jr., the health and human services secretary in the United States, held a recent news conference and made uninformed comments on autism. [...]
